Skip to content

Author

B. Feingold

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating HLA Donor-Specific Antibody.

Daratumumab was associated with significant improvements in dd-cfDNA, EMB-GEP, and antibody burden in pediatric and young adult HT recipients with ABMR, suggesting periodic maintenance dosing may be required.

Yuen-Lo-Yau Leung, Qing-Yong Xu, M. Zinn et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.